Yunbin B. Ye
Fuzhou, 350014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Cancer-associated fibroblast-derived vascular endothelial growth factor a promotes gastric cancer organoid growth and chemotherapy resistance via paracrine signaling.
Journal: Cellular signalling
Published: April 13, 2026
USP35 Acts as a Deubiquitinating Enzyme for ID3 to Promote Immune Escape in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 27, 2025
Bacterial outer membrane vesicles OMV-LL for delivery of neoantigen mRNA to induce anti-HCC therapy.
Bacterial outer membrane vesicles OMV-LL for delivery of neoantigen mRNA to induce anti-HCC therapy.
Journal: Frontiers in immunology
Published: May 22, 2025
Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma.
Journal: Cancer biology & medicine
Published: April 10, 2025
ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2025
Retraction Note: Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 27, 2025
SNRPB promotes gastric cancer progression via the ECM receptor signaling pathway.
Journal: Gene
Published: February 09, 2025
Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer.
Journal: Frontiers in pharmacology
Published: July 15, 2024
Targeting Nuclear Receptor Coactivator SRC-1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD-L1.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 20, 2023
EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway.
Journal: Annals of hepatology
Published: December 05, 2023
BCL2A1 neoepitope-elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer.
Journal: Journal of leukocyte biology
Published: October 27, 2023
Last Updated: 09/26/2026